In 66.6% of patients with ADPKD, multiple types of mutations in PKD1 and PKD2 (non-sense, frameshift, canonical splicing, and large rearrangements) result in structural disruption and loss of protein function, and these mutations are generally considered pathogenic. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.